I

INOVIQ
IIQ

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
A$48.57M
EV
A$42.43M
Shares Outstanding
138.78M
Beta
2.46
Industry
Medical - Diagnostics & Research

Wall Street View

Analyst Rating
NO_OPINION
Analyst Target Price
Number of Analysts
1
P/E 2026E
-
P/Revenue 2026E
53.97x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About INOVIQ Ltd

gainify

I

INOVIQ Ltd

IIQ

INOVIQ Ltd engages in the developing and commercializing of diagnostic and exosome‐based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as...

Sector

Healthcare

Industry

Medical - Diagnostics & Research

CEO

Hinch, Leearne

Employees

15

IPO Date

1988-01-28

Headquarters

23 Normanby Road, Notting Hill, Victoria, 3168, Australia

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.